NASDAQ:ILMN

Illumina - ILMN News Today

$219.77

-4.78 (-2.13%)

(As of 03/20/2023 12:00 AM ET)

Add

Compare

Today's Range: $216.85
▼
$223.82
50-Day Range: $193.75
▼
$228.15
52-Week Range: $173.45
▼
$371.16

Volume: 1.14 million shs
Average Volume: 1.41 million shs
Market Capitalization: $34.72 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $249.40

Institutional Ownership

Get Illumina News Delivered to You Automatically

ILMN Media Mentions By Week

ILMN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ILMN
News Sentiment
▼
-0.17

0.35
▲
Average
Medical
News Sentiment

ILMN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ILMN Articles
This Week
▼
20

9
▲
ILMN Articles
Average Week

Source

Source	Headline
	A. D. Beadell Investment Counsel Inc. Purchases Shares of 1,002 Illumina, Inc. (NASDAQ:ILMN) marketbeat.com - March 20 at 9:00 AM
	Stonnington Group LLC Cuts Position in Illumina, Inc. (NASDAQ:ILMN) marketbeat.com - March 19 at 9:19 AM
	S.A. Mason LLC Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN) marketbeat.com - March 17 at 11:26 AM
	Illumina, Inc. (NASDAQ:ILMN) Given Consensus Recommendation of "Hold" by Brokerages marketbeat.com - March 17 at 3:23 AM
	Illumina, Inc. (NASDAQ:ILMN) Shares Sold by West Oak Capital LLC marketbeat.com - March 16 at 9:45 AM
	S&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slides finance.yahoo.com - March 20 at 5:44 PM
	Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal cnbc.com - March 20 at 3:30 PM
	Illumina (NASDAQ:ILMN) Given New $300.00 Price Target at Royal Bank of Canada americanbankingnews.com - March 19 at 4:22 AM
	Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle cnbc.com - March 18 at 10:31 AM
	Illumina Should Heed Carl Icahn, Give Up on Grail finance.yahoo.com - March 17 at 5:29 PM
	UPDATE 1-Carl Icahn urges Fed to keep fighting inflation after SVB collapse - FT finance.yahoo.com - March 17 at 1:49 AM
	Illumina Inc. stock falls Tuesday, underperforms market marketwatch.com - March 16 at 4:53 AM
	Illumina Inc. stock rises Wednesday, outperforms market marketwatch.com - March 16 at 4:53 AM
	Illumina retains ‘Buy’ rating from Canaccord as activist investor Carl Icahn prepares for face-off proactiveinvestors.com - March 16 at 4:53 AM
	Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight ca.finance.yahoo.com - March 15 at 5:20 PM
	Illumina slaps back at activist investor Carl Icahn over Grail, board seats bizjournals.com - March 14 at 8:50 PM
	SVB May Be a Failure of Supervision. What It Means for Other Banks. finance.yahoo.com - March 14 at 10:12 AM
	Illumina launches its first product enabling long- and short-read sequencing on one instrument finance.yahoo.com - March 14 at 10:12 AM
	Illumina Surges As Activist Investor Carl Icahn Attempts To Wrest Control finance.yahoo.com - March 13 at 6:30 PM
	Illumina jumps 20% as Carl Icahn starts proxy battle over Grail deal (update) seekingalpha.com - March 13 at 2:36 PM
	Illumina, Seagen And Other Big Stocks Moving Higher On Monday benzinga.com - March 13 at 12:31 PM
	ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina investorplace.com - March 13 at 12:03 PM
	Carl Icahn Issues Open Letter to Illumina : investing.com - March 13 at 10:54 AM
	WSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billion finance.yahoo.com - March 13 at 8:40 AM
	UPDATE 1-Carl Icahn prepares for proxy fight at Illumina - WSJ finance.yahoo.com - March 12 at 10:39 PM
	Carl Icahn prepares for proxy fight at Illumina - WSJ finance.yahoo.com - March 12 at 10:39 PM
	Carl Icahn Prepares for Proxy Fight at Illumina wsj.com - March 12 at 10:17 PM
	Carl Icahn Plans Illumina Proxy Fight - WSJ investing.com - March 12 at 9:51 PM
	Children’s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancer finance.yahoo.com - March 10 at 6:48 PM
	How Is The Market Feeling About Illumina? msn.com - March 7 at 5:49 AM
	A Look Into Illumina's Debt msn.com - March 7 at 5:49 AM
	Myriad Genetics' (MYGN) New Pact to Extend HRD Testing Access finance.yahoo.com - March 3 at 5:07 PM
	A New Genomic Atlas Could Help Save Endangered Elephants finance.yahoo.com - March 2 at 1:43 PM
	Working To Solve Rare Disease and Support Patients finance.yahoo.com - February 28 at 1:35 PM
	John Hancock expands access to Galleri®, GRAIL's breakthrough cancer screening technology finance.yahoo.com - February 23 at 9:38 AM
	Startups Take On Illumina in Race for Cheaper DNA Sequencing finance.yahoo.com - February 16 at 7:17 PM
	Continue To Avoid Illumina Inc seekingalpha.com - February 16 at 7:52 AM
	Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease finance.yahoo.com - February 15 at 2:06 PM
	Illumina Faces Rival Gene Sequencers and Price Competition finance.yahoo.com - February 14 at 2:59 PM
	Illumina Receives Highest Distinction in the 2023 S&P Global Sustainability Yearbook finance.yahoo.com - February 10 at 1:17 PM
	Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript finance.yahoo.com - February 9 at 8:28 PM
	A New Era for Discoveries at Admera Health finance.yahoo.com - February 9 at 3:27 PM
	Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute finance.yahoo.com - February 8 at 1:41 PM
	The Brazilian billionaires embroiled in a $3.9bn scandal finance.yahoo.com - February 8 at 8:40 AM
	Illumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates finance.yahoo.com - February 8 at 8:40 AM
	Oxford Nanopore: Illumina's Formidable Challenger seekingalpha.com - February 8 at 2:45 AM
	The Wild Card That Keeps Haunting DNA-Reading Giant Illumina finance.yahoo.com - February 7 at 10:14 PM
	Illumina (ILMN) Misses Q4 Earnings Estimates finance.yahoo.com - February 7 at 10:14 PM
	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022 finance.yahoo.com - February 7 at 5:13 PM
	DNA-Reading Giant Illumina Topples On Wide Profit Miss finance.yahoo.com - February 7 at 5:13 PM
	Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings finance.yahoo.com - February 7 at 2:11 AM
	Illumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparison seekingalpha.com - February 6 at 3:00 AM
	How Organizations Around the World Are Closing the Cancer Care Gap finance.yahoo.com - February 3 at 12:54 PM
	Illumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Year finance.yahoo.com - February 1 at 1:48 PM
	Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders finance.yahoo.com - January 31 at 2:57 PM

Get Illumina News Delivered to You Automatically

This page (NASDAQ:ILMN) was last updated on 3/20/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Illumina - ILMN News Today

ILMN Media Mentions By Week

ILMN Media Sentiment

ILMN News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info